We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of eiRNA Therapy

News   May 03, 2007

 
Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of eiRNA Therapy
 
 
 

RELATED ARTICLES

Timing Is Key in Cell Protein Production

News

Scientists at the University of Sheffield have discovered how genes create proteins in research which could aid the development of treatments for human diseases.

READ MORE

More Effective Drug Combination Regimens to Treat TB Faster

News

UCLA researchers have identified a way to significantly reduce the duration of tuberculosis treatment using an approach called "artificial intelligence-parabolic response surface."

READ MORE

Statins’ Potential to Treat MS Unrelated to Lowering Cholesterol

News

The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) - for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, a UCL study has found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE